jan hein cornel
jan hein cornel
Cardiologist, Northwest Clinics, Alkmaar , Radboudumc, Nijmegen, The Netherlands
Verified email at
Cited by
Cited by
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Rosuvastatin in older patients with systolic heart failure
J Kjekshus, E Apetrei, V Barrios, M Böhm, JGF Cleland, JH Cornel, ...
New England Journal of Medicine 357 (22), 2248-2261, 2007
Lenient versus strict rate control in patients with atrial fibrillation
IC Van Gelder, HF Groenveld, HJGM Crijns, YS Tuininga, JGP Tijssen, ...
New England Journal of Medicine 362 (15), 1363-1373, 2010
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
Apixaban with antiplatelet therapy after acute coronary syndrome
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine 365 (8), 699-708, 2011
Colchicine in patients with chronic coronary disease
SM Nidorf, ATL Fiolet, A Mosterd, JW Eikelboom, A Schut, TSJ Opstal, ...
New England journal of medicine 383 (19), 1838-1847, 2020
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study
ML Simoons, W Rutsch, A Vahanian, J Adgey, A Maseri, C Vassanelli, ...
Lancet 349 (9063), 1429-1435, 1997
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
HL Hillege, D Nitsch, MA Pfeffer, K Swedberg, JJV McMurray, S Yusuf, ...
Circulation 113 (5), 671-678, 2006
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial
SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho, JJP Kastelein, ...
Jama 316 (22), 2373-2384, 2016
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ...
New England journal of medicine 367 (14), 1297-1309, 2012
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled …
PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ...
The Lancet 391 (10118), 319-328, 2018
Early invasive versus selectively invasive management for acute coronary syndromes
RJ de Winter, F Windhausen, JH Cornel, PHJM Dunselman, CL Janus, ...
New England Journal of Medicine 353 (11), 1095-1104, 2005
Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary …
JJ Bax, W Wijns, JH Cornel, FC Visser, E Boersma, PM Fioretti
Journal of the American College of Cardiology 30 (6), 1451-1460, 1997
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ...
European heart journal 31 (24), 3006-3016, 2010
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ...
Circulation 122 (11), 1056-1067, 2010
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable …
JJ Bax, D Poldermans, A Elhendy, JH Cornel, E Boersma, R Rambaldi, ...
Journal of the American College of Cardiology 34 (1), 163-169, 1999
Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure
BM Everett, JH Cornel, M Lainscak, SD Anker, A Abbate, T Thuren, ...
Circulation 139 (10), 1289-1299, 2019
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
RC Becker, JP Bassand, A Budaj, DM Wojdyla, SK James, JH Cornel, ...
European heart journal 32 (23), 2933-2944, 2011
The system can't perform the operation now. Try again later.
Articles 1–20